Nagarajan Rajaram, Robison Leslie L
Pediatric Epidemiology and Clinical Research, University of Minnesota, MMC 484, 420 Delaware St. SE, Minneapolis, MN 55455, USA.
J Natl Cancer Inst Monogr. 2005(34):72-6. doi: 10.1093/jncimonographs/lgi020.
During the past several decades, survival rates of many childhood cancers have risen at a remarkable pace. The ever-growing population of cancer survivors is at potential risk for developing a broad spectrum of adverse outcomes relating to cancer diagnosis and treatment, including infertility, adverse pregnancy-related outcomes, and health problems of offspring. Unfortunately, these topics have not been extensively studied, particularly among pediatric cancer survivors receiving more recent therapies. Based on the current literature, therapy for childhood cancer, in general, does not appear to have a significant impact on pregnancy outcomes and on the health of offspring of childhood cancer survivors. Additional investigations, incorporating more rigorous designs, need to be conducted to further address potential long-term risks relating to birth outcomes, including birth weight. Studies currently underway to evaluate the incidence of and risk factors for birth defects, occurrence of cancer, and other serious health-related outcomes will provide valuable information to guide researchers, clinicians, and survivors and their families.
在过去几十年中,许多儿童癌症的生存率以惊人的速度上升。癌症幸存者的数量不断增加,他们面临着一系列与癌症诊断和治疗相关的不良后果的潜在风险,包括不孕、不良妊娠相关结局以及后代的健康问题。不幸的是,这些话题尚未得到广泛研究,尤其是在接受最新疗法的儿科癌症幸存者中。根据目前的文献,一般来说,儿童癌症治疗似乎对妊娠结局和儿童癌症幸存者后代的健康没有显著影响。需要进行更多设计更严谨的调查,以进一步解决与出生结局(包括出生体重)相关的潜在长期风险。目前正在进行的评估出生缺陷的发生率和风险因素、癌症的发生以及其他严重健康相关结局的研究,将为指导研究人员、临床医生以及幸存者及其家人提供有价值的信息。